Syndromic rapid testing with BIOFIRE® RP 2.1 including detection of SARS-CoV-2 + 21 additional respiratory pathogens in ~45 minutes
SARS-COV-2 R-GENE®: open platform real-time Polymerase Chain Reaction, results reported in 4-5 hours
NUCLISENS® Extraction Systems: EMAG®, easyMAG® equipment/reagents essential for extraction of nucleic acids used on several SARS-CoV-2 RT-PCR tests
Automated qualitative assays for detection of IgM and IgG VIDAS® SARS-COV-2 IgM & IgG, results in 27 min
A range of biomarkers and other tests to support risk assessment for potential COVID-19 complications: BIOFIRE® PNEUMONIA PANEL, VIDAS BRAHMSTM PCT, D-DIMER EXCLUSION IITM and NEPHROCHECK®Test [TIMP-2 • IGFBP-7]
Complemented with a broader range of microbiology solutions: Blood Culture (BACT/ALERT® VIRTUO®) and Identification and Susceptibility Testing (VITEK® MS, VITEK® 2, ETEST®)
Surveillance and epidemiology solutions: BIONUMERICS®SARS-CoV-2 Plug-In, BIOMERIEUX CLARIONTM